GNOM Among Technology ETFs
End-of-day Nov 20, 2026 · 54 Technology ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.6% | −7.4% | −13.5% | −12.4% | +25.7% | +36.0% | +43.8% | −33.0% | — | −5.8% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$52 of every $1,000 in GNOM is Praxis
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | PRAXPraxis Precision Medicines I | Healthcare | 5.22% | $522.40 | 16K | $5.4M |
| 2 | MRNAModerna | Healthcare | 4.74% | $474.03 | 22K | $4.9M |
| 3 | BMRNBiomarin Pharmaceutical | Healthcare | 4.64% | $464.49 | 83K | $4.8M |
| 4 | VRTXVertex Pharmaceuticals | Healthcare | 4.62% | $462.13 | 8,808 | $4.7M |
| 5 | TECHBio-techne | Healthcare | 4.55% | $455.19 | 64K | $4.7M |
| 6 | QGENQiagen | Healthcare | 4.51% | $450.53 | 93K | $4.6M |
| 7 | BNTXBiontech SE | Healthcare | 4.42% | $442.16 | 53K | $4.5M |
| 8 | GHGuardant Health | Healthcare | 3.78% | $377.62 | 26K | $3.9M |
| 9 | ARWRArrowhead Pharmaceuticals IN | Healthcare | 3.61% | $360.68 | 77K | $3.7M |
| 10 | NTRANatera | Healthcare | 3.42% | $342.14 | 11K | $3.5M |
| 11 | CRSPCrispr Therapeutics AG | Healthcare | 3.31% | $330.88 | 80K | $3.4M |
| 12 | ILMNIllumina | Healthcare | 3.26% | $325.80 | 16K | $3.3M |
| 13 | CDNACaredx | Healthcare | 3.20% | $319.84 | 42K | $3.3M |
| 14 | TXG10X Genomics | Healthcare | 3.16% | $316.28 | 56K | $3.2M |
| 15 | 1548.HKGenscript Biotech | Healthcare | 3.10% | $309.58 | 821K | $3.2M |
of the $345B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines I | 5.22% |
| 2 | MRNA | Moderna | 4.74% |
| 3 | BMRN | Biomarin Pharmaceutical | 4.64% |
| 4 | VRTX | Vertex Pharmaceuticals | 4.62% |
| 5 | TECH | Bio-techne | 4.55% |
| 6 | QGEN | Qiagen | 4.51% |
| 7 | BNTX | Biontech SE- | 4.42% |
| 8 | GH | Guardant Health | 3.78% |
| 9 | ARWR | Arrowhead Pharmaceuticals IN | 3.61% |
| 10 | NTRA | Natera | 3.42% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 29, 2026 | Jul 7, 2026 | $0.0579 |
| Dec 30, 2025 | Jan 7, 2026 | $0.59 |
| Jun 27, 2025 | Jul 7, 2025 | $0.0331 |
| Dec 30, 2021 | Jan 7, 2022 | $0.0280 |
| Dec 30, 2020 | Jan 8, 2021 | $0.13 |